---
title: "BIOCAUSE HEILEN PHARMA: Febuxostat tablets have obtained a drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261999283.md"
description: "According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA announced that the company recently received the \"Drug Registration Certificate\" approved and issued by the National Medical Products Administration, for the drug Febuxostat Tablets. Febuxostat Tablets are a xanthine oxidase inhibitor, primarily used for the long-term treatment of hyperuricemia and gout patients (including urate-lowering treatment after acute attacks of gouty arthritis)"
datetime: "2025-10-21T07:59:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261999283.md)
  - [en](https://longbridge.com/en/news/261999283.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261999283.md)
---

# BIOCAUSE HEILEN PHARMA: Febuxostat tablets have obtained a drug registration certificate

According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration. The related drug is Febuxostat Tablets. Febuxostat Tablets are a xanthine oxidase inhibitor, mainly used for the long-term treatment of hyperuricemia and gout patients (including urate-lowering treatment after acute attacks of gouty arthritis)

### Related Stocks

- [301211.CN](https://longbridge.com/en/quote/301211.CN.md)

## Related News & Research

- [Investors Can Find Comfort In Polaris Media's (OB:POL) Earnings Quality](https://longbridge.com/en/news/287004804.md)
- [15:37 ETMuse Communications Celebrates 10 Years of Award-Winning Legal Marketing and Public Relations](https://longbridge.com/en/news/286811115.md)
- [US Senator Durbin urges RFK. Jr to resist easing vape rules](https://longbridge.com/en/news/287079463.md)
- [Iran war driving Iowa fertilizer prices to record highs](https://longbridge.com/en/news/286985327.md)
- [Apple Flavor to Buy NovoSana’s China Assets for Up to USD66 Million in Health Supplements Push](https://longbridge.com/en/news/287039106.md)